AI Healthcare Stock Has Bullish Setup, Expert Says
Source: Clive Maund (04/22/2024)
Technical Analyst Clive Maund reviews Treatment.com AI's charts and the recent influx of news to explain why he believes it is a Strong Buy.
read more >
Biopharma's New Drug for COPD Likely to be Approved
Source: Ram Selvaraju (04/22/2024)
Characteristics of the Buy-rated company's lead candidate make it "an intriguing commercial prospect," noted an H.C. Wainwright & Co. report.
read more >
PDUFA Date Coming Up for U.K. Biopharma
Source: Edward Nash (04/22/2024)
The company has a commercialization plan in place and is preparing further for approval, noted a Canaccord Genuity report.
read more >
Analyst Says Pharma Co. Has No True Competitor
Source: Andrew Tsai (04/19/2024)
Verona Pharma Plc. recently is gearing up for a potential FDA approval of its twice-daily ensifentrine, according to a Jefferies & Co. research note.
read more >
LA Biotech's Lower Revenue Will Be Short Lived
Source: Dr. Jonathan Aschoff (04/17/2024)
While Ontrak Inc. may have had a loss in revenue in 2023, this will be short-lived, according to a Roth MKM research note.
read more >